Trivium Point Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Trivium Point Advisory's ARKG Position: Q1 2026 in Review
Trivium Point Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 34,397 shares — an estimated $996K sold.
Trivium Point Advisory first reported a position in ARKG in Q3 2025 and held it in 2 quarters. The position peaked at $1.04M in Q3 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Trivium Point Advisory reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
- Trivium Point Advisory sold 34,397 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $996K.
- Trivium Point Advisory first reported a position in ARK Genomic Revolution ETF in Q3 2025 and held it in 2 quarters.
- Trivium Point Advisory's ARK Genomic Revolution ETF position peaked at $1.04M in Q3 2025.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Trivium Point Advisory's 13F filing for Q1 2026, filed 21 Apr 2026.